rs869025573
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP3PM2_SupportingPM6_StrongPS4_ModeratePS3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.71T>A (p.Ile24Asn) variant in NRAS is a missense variant predicted to cause substitution of isoleucine by asparagine at amino acid 24. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.863, which is above the threshold of 0.7, evidence that correlates with impact to NRAS function (PP3). This variant has been reported in 4 probands with features of RASopathy (PS4_Moderate; PMIDs:21263000, 22855653, 28594414, GeneDx). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 2 individuals with features of RASopathy (PM6_Strong; PMIDs: 21263000, 22855653). RAS activation assays in 293T cells showed a mild increase in GTP-bound RAS and enhanced MAPK phosphorylation indicating that this variant impacts protein function. A zebrafish model using injected RNA showed developmental and craniofacial defects. The phenotype was completely rescued by MEK inhibition (PMID:21263000)(PS3_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: PM6_Strong, PS4_Moderate, PS3_Supporting, PM2_Supporting, PP3. (RASopathy VCEP specifications version 2.1; 9/17/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA356968/MONDO:0021060/039
Frequency
Consequence
NM_002524.5 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Noonan syndrome 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- cardiofaciocutaneous syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
- Costello syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002524.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NRAS | NM_002524.5 | MANE Select | c.71T>A | p.Ile24Asn | missense | Exon 2 of 7 | NP_002515.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NRAS | ENST00000369535.5 | TSL:1 MANE Select | c.71T>A | p.Ile24Asn | missense | Exon 2 of 7 | ENSP00000358548.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at